|
HELLS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.6268000000046E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73717999999434E-05 |
| Normal-vs-Stage2 |
2.549200E-01 |
| Normal-vs-Stage3 |
1.244390E-03 |
| Normal-vs-Stage4 |
7.843800E-03 |
| Stage1-vs-Stage2 |
3.879900E-03 |
| Stage1-vs-Stage3 |
3.807600E-01 |
| Stage1-vs-Stage4 |
3.429600E-01 |
| Stage2-vs-Stage3 |
4.395700E-02 |
| Stage2-vs-Stage4 |
1.041030E-01 |
| Stage3-vs-Stage4 |
8.056400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51719999999367E-05 |
| Normal-vs-AfricanAmerican |
4.298100E-03 |
| Normal-vs-Asian |
2.355600E-04 |
| Caucasian-vs-AfricanAmerican |
6.430400E-01 |
| Caucasian-vs-Asian |
8.610200E-01 |
| AfricanAmerican-vs-Asian |
7.521600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.701400E-03 |
| Normal-vs-Female |
4.01159999999789E-05 |
| Male-vs-Female |
3.088200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.42159999947123E-07 |
| Normal-vs-Age(41-60Yrs) |
3.337300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.344400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.320820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.785900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.521500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.644600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.856600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.392600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.759800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.177000E-01 |
| Classical-VS-Follicular |
1.33059999996021E-06 |
| Classical-VS-Other |
9.207600E-01 |
| Classical-VS-Normal |
1.12090000004006E-06 |
| Tall-VS-Follicular |
1.120020E-03 |
| Tall-VS-Other |
8.397400E-01 |
| Tall-VS-Normal |
2.233500E-04 |
| Follicular-VS-Other |
1.516810E-01 |
| Follicular-VS-Normal |
3.638000E-01 |
| Other-VS-Normal |
8.363900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.636640E-03 |
| Normal-vs-N1 |
7.431900E-04 |
| N0-vs-N1 |
2.463600E-01 |
|
|
